Home › NDC Lookup › RxCUI directory › RxCUI 153183

Adapalene 0.001 MG/MG Topical Gel [Differin] — RxCUI 153183

RxNorm drug concept · Semantic branded drug
RxCUI 153183 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI153183
Official nameAdapalene 0.001 MG/MG Topical Gel [Differin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDifferin 0.1 % Topical Gel; Differin 0.001 MG/MG Topical Gel; Differin 1 MG per GM Topical Gel
FDA products mapped1
Package NDCs mapped5
Reported Medicaid activity (SDUD)1,048 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adapalene: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats acne vulgaris, the common type of acne. Some products are labeled for ages 12 and up. Ask a doctor before using it in younger children.
  • Use it once a day, usually in the evening, on clean, dry skin. Apply a thin layer to the whole affected area and keep it away from your eyes, lips and inside of your mouth or nose....
  • Give it about 8 to 12 weeks. Acne can seem to flare in the early weeks, which is not a reason to stop. If you see no improvement after 12 weeks, talk to your prescriber.
  • Redness, dryness, peeling and some burning or stinging are the most common, especially in the first month. They are usually mild to moderate and often ease. A moisturizer can help....
📖 Read our full Adapalene guide →

🕸️ Concept Web — How Adapalene 0.001 MG/MG Topical Gel [Differin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Adapalene 0.001 MG/MG Topical Gel [Differin] RxCUI 153183

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Adapalene 60223
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Differin 153184
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adapalene Topical Gel 377966
    • Adapalene Topical Product 1163694
    • Adapalene Topical Gel [Differin] 370379
    • Differin Topical Product 1167536
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Adapalene 0.001 MG/MG Topical Gel SCD · 307731
  • Adapalene 0.001 MG/MG SCDC · 340054
  • Adapalene Topical Gel SCDF · 377966
  • Adapalene Topical Product SCDG · 1163694

Brand-Name Concepts

  • Adapalene 0.001 MG/MG [Differin] SBDC · 565195
  • Adapalene Topical Gel [Differin] SBDF · 370379
  • Differin Topical Product SBDG · 1167536
  • Differin BN · 153184

📦 FDA Products & Package NDCs

1 product · 5 package NDCs
5 package NDCs map to RxCUI 153183 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00299-4910-00 1 TUBE in 1 BLISTER PACK (0299-4910-00) / 2 g in 1 TUBE Differin Galderma Laboratories, L.P. 2016-07-08
00299-4910-10 1 BOTTLE, PUMP in 1 CARTON (0299-4910-10) / 15 g in 1 BOTTL... Differin Galderma Laboratories, L.P. 2020-01-01
00299-4910-15 1 TUBE in 1 CARTON (0299-4910-15) / 15 g in 1 TUBE Differin Galderma Laboratories, L.P. 2016-07-08
00299-4910-40 1 BOTTLE, PUMP in 1 CARTON (0299-4910-40) / 45 g in 1 BOTTL... Differin Galderma Laboratories, L.P. 2020-01-01
00299-4910-45 1 TUBE in 1 CARTON (0299-4910-45) / 45 g in 1 TUBE Differin Galderma Laboratories, L.P. 2016-07-08
Observed labelers: Galderma Laboratories, L.P. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.